Connexin 32 deficiency protects the liver against ischemia/reperfusion injury.
In conclusion Cx32 is a novel regulator of hepatic I/R injury through the modulation of hepatocyte apoptosis and damage, largely via the p53/puma signaling pathway.
PMID: 32147436 [PubMed - as supplied by publisher]
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Wu S, Yao W, Chen C, Chen H, Huang F, Liu Y, Cai J, Yuan D, Hei Z Tags: Eur J Pharmacol Source Type: research
More News: Diprivan | Drugs & Pharmacology | Liver | Liver Transplant | Propofol | Study | Transplants | Urology & Nephrology